Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors.

MLA

van de Beek, Irma, et al. “Combined Germline Pathogenic Variants in FLCN and TP53 Are Associated with Early Onset Renal Cell Carcinoma and Brain Tumors.” Molecular Genetics & Genomic Medicine, vol. 11, no. 2, Feb. 2023, p. e2098. EBSCOhost, https://doi.org/10.1002/mgg3.2098.

APA

van de Beek, I., Glykofridis, I. E., Wagner, A., den Toom, D. T., Bongers, E. M. H. F., van Leenders, G. J. L. H., Johannesma, P. C., Meijers-Heijboer, H. E. J., Wolthuis, R. M. F., van Steensel, M. A. M., Dubbink, H. J., & Houweling, A. C. (2023). Combined germline pathogenic variants in FLCN and TP53 are associated with early onset renal cell carcinoma and brain tumors. Molecular Genetics & Genomic Medicine, 11(2), e2098. https://doi.org/10.1002/mgg3.2098

Chicago

van de Beek, Irma, Iris E Glykofridis, Anja Wagner, Dorine T den Toom, Ernie M H F Bongers, Geert J L H van Leenders, Paul C Johannesma, et al. 2023. “Combined Germline Pathogenic Variants in FLCN and TP53 Are Associated with Early Onset Renal Cell Carcinoma and Brain Tumors.” Molecular Genetics & Genomic Medicine 11 (2): e2098. doi:10.1002/mgg3.2098.